GlassScriptPhysician profile
Rafael Gonzalez
NPI 1851349997
$3,299.98
in general payments reported to CMS, 2019-2025
19 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $271 · 2022: $166 · 2023: $1,020 · 2024: $723 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,047 · Debt Forgiveness: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,047.01 |
| Debt Forgiveness | $371.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $662.62 | 2019-2025 | Augment Injectable, Prostep Mica, Viaflow |
| Djo, LLC | $371.27 | 2023 | |
| Kerecis Limited | $335.29 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $301.19 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $259.12 | 2023-2025 | Memofix Super Elastic Nitinol Staple System, Panta 2, Small Cannulated Screws |
| Davol INC. | $191.04 | 2020 | |
| Treace Medical Concepts, INC. | $168.09 | 2024 | |
| Depuy Synthes Sales INC. | $144.48 | 2019-2024 | Motoband, Minibunion, Motoband Cp |
| Triad Life Sciences INC. | $141.37 | 2022 | |
| Axogen | $136.30 | 2019-2023 | Avance Nerve Graft |
| Paratek Pharmaceuticals, INC. | $124.98 | 2025 | Nuzyra |
| Solventum Corporation | $124.15 | 2024 | Activ.A.C. |
| Osiris Therapeutics INC. | $121.58 | 2019 | |
| Paragon 28, INC. | $119.99 | 2025 | Ankle Fracture |
| Musculoskeletal Transplant Foundation INC. | $21.71 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $20.64 | 2019 | |
| Organogenesis INC. | $19.92 | 2019 | |
| Kci USA, INC. | $18.49 | 2019 | |
| Melinta Therapeutics, LLC | $17.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.